Previous 10 | Next 10 |
Ignorance is relatively easy to overcome; stupidity is much harder. "― Marty Rubin Today, we take a look at a stock that has fallen on some hard times as it jettisoned its long-term CEO and faced other short-term challenges. However, with management changes and other potential cata...
It is no secret that prescription drug prices in America are the highest among all developed nations. A variety of factors have contributed to the issue, such as a lack of universal healthcare coverage, the staggering cost of conducting clinical trials to get drugs to approval, and price gougin...
BAUDETTE, Minn. , June 1, 2020 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) announced today that it continues to make progress toward addressing items identified in the Refusal to File letter received from the FDA relating to its Cortrophin® Gel sNDA f...
ANI Pharmaceuticals, Inc. (ANIP) Q1 2020 Earnings Conference Call May 7, 2020 10:30 A.M. ET Company Participants Arthur Przybyl - Chief Executive Officer Stephen Carey - Chief Financial Officer Patrick Walsh - ANI Board Member Conference Call Participants Presentation ...
Image source: The Motley Fool. ANI Pharmaceuticals Inc (NASDAQ: ANIP) Q1 2020 Earnings Call May 8, 2020 , 8:30 p.m. ET Operator Continue reading
ANI Pharmaceuticals (NASDAQ: ANIP ): Q1 Non-GAAP EPS of $1.04 beats by $0.15 ; GAAP EPS of -$0.59 misses by $0.58 . More news on: ANI Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
BAUDETTE, Minn. , May 7, 2020 /PRNewswire/ -- For the first quarter 2020, ANI reports: Net revenues of $49.8 million versus $52.9 million in 2019 GAAP net loss of $7.0 million and diluted GAAP loss per share of $0.59 Adjusted non-GAAP EBITDA of $17.6 million ...
BAUDETTE, Minn. , April 30, 2020 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its first quarter 2020 financial results on Thursday, May 7, 2020 , before the opening of the U.S. financial markets. The earnings press releas...
BAUDETTE, Minn. , April 29, 2020 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that it received a Refusal to File (RTF) letter from the U.S. Food and Drug Administration (FDA) regarding its supplemental new drug application (sNDA) for Cortrophi...
H.P. Acthar Gel is a corticotropin injection approved to treat 19 indications, including multiple sclerosis, rheumatoid arthritis, and infantile spasms. The anti-seizure drug often requires daily dosing, and only had a list price of $40 per vial in 2000. Fast forward 20 years later, the dru...
News, Short Squeeze, Breakout and More Instantly...
ANI Pharmaceuticals Inc. Company Name:
ANIP Stock Symbol:
NASDAQ Market:
ANI Pharmaceuticals Inc. Website:
PRINCETON, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2024 financial results on Tuesday, August 6, 2024, prior to the market open. Nikh...
PRINCETON, N.J., July 15, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), the Company launched L-Glutamine Oral Po...
2024-07-09 17:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...